Most Claims In Amiodarone Death Case Dismissed With Leave To Refile

Mealey's (March 6, 2019, 11:08 AM EST) -- FRESNO, Calif. — A California federal judge on Feb. 14 dismissed various claims against Pfizer Inc. and Mylan Institutional Inc. in a wrongful death case involving the anti-arrhythmia heart drug amiodarone...
To view the full article, register now.